Carpenter, Kimberly L. H. http://orcid.org/0000-0002-3838-798X
Baranek, Grace T.
Copeland, William E.
Compton, Scott
Zucker, Nancy
Dawson, Geraldine
Egger, Helen L.
Funding for this research was provided by:
National Institute of Mental Health (R01-MH-081025, R01-MH-075766)
U.S. Department of Defense (W81XWH-14-1-0526)
Brain and Behavior Research Foundation (23807)
Article History
First Online: 19 December 2018
Compliance with Ethical Standards
:
: Dr Dawson reports grants and personal fees from Janssen Research, Akili, from LabCorp, Inc, Roche Pharmaceutical Co, ViaCord, Guilford Press, Oxford University Press, and Springer Naturek; grants from NICHD 1P50HD093074 and Progenity, Inc. in addition, Dr Dawson has a patent number 62757234 pending, a patent number 62757226 pending, a patent number 15141391 pending, and a patent number 62470431 pending. Dr. Egger is on the Scientific Advisory Board of Autoimmune Encephalitis Alliance. Dr. Compton recieves research support from the NC GlaxoSmithKline Foundation, Murison, Inc, and has served as a consultant for Shire. He has recieved honoraria from the Journal of Consulting and Clinical Psychology, Nordic Long-Term OCD treatment Study Research Group, and the Centre for Child and Adolescent Mental Health, Eastern and Southern Norway. He has also given expert testimony for Duke University No other authors have any ptoential conflicts of interest to declare.